Nordic BioSite completed the acquisition of LubioScience.

Nordic BioSite, a supplier of products for research and diagnostics, completed the acquisition of LubioScience, a company that offers a select range of R&D products for protein biochemistry, cell culture and general lab reagents of high quality. Financial terms were not disclosed. “Switzerland is a key research hub in Europe and hence we have been eager to be present there to help existing and new suppliers gain access to this fast-growing market. LubioScience has been #1 on our target list for a long time as we have been impressed with the success they have had in the Swiss market. I am sure there are many things we can learn from their success to replicate within the Group, just like we can transfer our commercial and operational best practices to LubioScience” Sune Schmolker, Nordic BioSite CEO.